Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth ...

Shares of Globus Spirits extended its loss to second consecutive day, down over 16 percent to Rs 890 per share on November 13 ...

Morgan Stanley raised the firm’s price target on Globus Medical (GMED) to $83 from $74 and keeps an Equal Weight rating on ...

Globus Spirits recorded a revenue of Rs 8741.1 crore, up 18.3 per cent, as compared to Rs 739 crore a year ago.

The Globus family of brands has launched a Black Friday sale offering discounts on 2025 travel, with Avalon Waterways ...

Shares of Globus Spirits Ltd declined 11% on November 12 as the spirits firm reported 88% drop in standalone net profit at Rs ...

The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major ...

Globus Medical, Inc.'s ( NYSE:GMED ) recent soft profit numbers didn't appear to worry shareholders, as the stock ...

Amalgamated Bank trimmed its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.4% in the third quarter, ...

Globus Medical, Inc. (NYSE: GMED) has unveiled its financial success for the third quarter of 2024, showcasing notable growth ...

Globus Medical and NuVasive's merger marked its first year on Sept. 1, Globus' CEO Dan Scavilla said in a Nov. 5 earnings call.

Globus Medical Inc. (GMED)股价飙升至52周新高，达到76.06美元的价格水平，显示投资者对这家医疗设备公司有强烈信心。这一高点出现在Globus Medical表现突出的一年中，过去一年其股价已上涨61.58%。该公司在肌肉骨骼解决方案市场的创新贡献继续吸引投资者兴趣，并在竞争激烈的行业中巩固其财务地位，这反映了公司的强劲表现。 在其他近期新闻中，Globus Medic ...